Shin Min-Jeong, Kanaya Alka M, Krauss Ronald M
Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA 94609, USA.
Atherosclerosis. 2008 Jun;198(2):313-9. doi: 10.1016/j.atherosclerosis.2007.10.004. Epub 2007 Dec 3.
We tested whether single nucleotide polymorphisms (SNPs) in the PPARalpha gene (PPARA) are associated with variations in levels of plasma apolipoprotein CIII (apoCIII) levels, as well as other lipids and lipoproteins, in African-Americans and Caucasians.
We initially identified an intronic SNP (rs4253728) in PPARA that was associated with plasma apoCIII level (p<0.05) in a subset of 435 individuals from the total study population (n=944; 335 African-Americans and 609 Caucasians). This SNP was then genotyped in a second subset of 476 individuals (total 911 subjects with available data), and a previously described PPARA coding SNP (L162V) which was shown to be in moderate linkage disequilibrium with the intronic SNP (r(2)=0.18) was genotyped in 928 subjects from the same study population. The minor allele frequencies for both SNPs were significantly lower in African-Americans compared with Caucasians (7.2% vs. 27.3% for rs4253728, 1.5% vs. 6.1% for L162V, both p<0.0001). African-Americans had significantly lower levels of TG and apoCIII compared with Caucasians after adjusting for age, sex, body mass index (BMI), waist circumference and other baseline characteristics. However, racial differences in TG levels were attenuated after adjusting for apoCIII levels. The minor alleles for both PPARA SNPs were associated with higher TG and apoCIII levels. Race modified the associations of L162V with TG (p for interaction=0.0056) and apoCIII (p for interaction=0.0011). Levels of both TG and apoCIII were lower in African-American but not Caucasian homozygotes for the major allele compared with carriers of the minor allele. Similar results were obtained for the intronic SNP, but the findings were no longer significant in a model that also contained L162V.
Two PPARA SNPs, L162V and rs4253728 (intronic), are less prevalent in African-Americans than in Caucasians and in African-Americans only are associated with higher apoCIII and TG levels.
我们测试了过氧化物酶体增殖物激活受体α基因(PPARα,即PPARA)中的单核苷酸多态性(SNP)是否与非裔美国人和高加索人的血浆载脂蛋白CIII(apoCIII)水平以及其他脂质和脂蛋白水平的变化相关。
我们最初在PPARA基因中鉴定出一个内含子SNP(rs4253728),该SNP与来自总研究人群(n = 944;335名非裔美国人和609名高加索人)的435名个体亚组中的血浆apoCIII水平相关(p<0.05)。然后在476名个体的第二个亚组中对该SNP进行基因分型(共有911名受试者有可用数据),并在来自同一研究人群的928名受试者中对先前描述的PPARA编码SNP(L162V)进行基因分型,该编码SNP与内含子SNP处于中度连锁不平衡状态(r² = 0.18)。与高加索人相比,非裔美国人中这两个SNP的次要等位基因频率均显著较低(rs4253728为7.2%对27.3%,L162V为1.5%对6.1%,两者p<0.0001)。在调整年龄、性别、体重指数(BMI)、腰围和其他基线特征后,非裔美国人的甘油三酯(TG)和apoCIII水平显著低于高加索人。然而,在调整apoCIII水平后,TG水平的种族差异有所减弱。PPARA这两个SNP的次要等位基因与较高的TG和apoCIII水平相关。种族改变了L162V与TG(交互作用p = 0.0056)和apoCIII(交互作用p = 0.0011)之间的关联。与次要等位基因携带者相比,非裔美国人中主要等位基因纯合子的TG和apoCIII水平均较低,但高加索人并非如此。内含子SNP也得到了类似结果,但在同时包含L162V的模型中,这些发现不再显著。
两个PPARA SNP,L162V和rs4253728(内含子),在非裔美国人中的流行程度低于高加索人,且仅在非裔美国人中与较高的apoCIII和TG水平相关。